Related Experiment Video
Updated: May 10, 2025
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Transfusion frequency, ferritin, and carotid intima media thickness in transfusion-dependent thalassemia patients
Rahmat Cahyanur1, Muhammad Ikhsan1, Shabrina Tadjoedin1
1Universitas Indonesia, Jakarta, Indonesia.
Insights
Carotid intima-media thickness (cIMT) may indicate atherosclerosis in thalassemia patients. Further research is needed to clarify the association between cIMT and cardiovascular risk in this population.
Area of Science:
- Vascular biology
- Hematology
- Cardiovascular medicine
Background:
- Carotid intima-media thickness (cIMT) is an atherosclerosis marker linked to cardiovascular disease risk.
- Thalassemia is associated with endothelial dysfunction due to iron overload, reduced nitric oxide, and lipid peroxidation.
- Existing studies on atherosclerosis markers in thalassemia patients yield inconsistent findings.
Purpose of the Study:
- To investigate carotid intima-media thickness (cIMT) as a potential marker for atherosclerosis in thalassemia patients.
- To explore the relationship between cIMT and cardiovascular risk factors in individuals with thalassemia.
Main Methods:
- Utilizing ultrasound to measure carotid intima-media thickness (cIMT).
- Assessing endothelial function markers.
- Analyzing lipid profiles and iron levels in thalassemia patients.
Main Results:
- Preliminary data suggests potential alterations in cIMT in thalassemia patients.
- Further analysis is required to establish a definitive link between cIMT and cardiovascular risk in this cohort.
Conclusions:
- Carotid intima-media thickness (cIMT) warrants further investigation as a potential biomarker for atherosclerosis in thalassemia.
- Clarifying the role of cIMT may improve cardiovascular risk assessment in thalassemia patients.
Introduction:
The carotid tunica intima-media thickness (cIMT) is an early marker of atherosclerosis and associated with an increased risk of cardiovascular diseases. Endothelial dysfunction also contributed with the increased cardiovascular risk in thalassemia caused by iron accumulation, reduced nitric oxide, and increased lipid peroxidation. Studies about atherosclerosis markers in thalassemia patients show inconsistent results.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...